Rethinking inflammation

The vagus nerve, neural control, and why chronic disease clusters

In many clinical settings today, inflammation is typically understood as a purely biochemical phenomenon. Cytokine levels rise, immune cells are activated, tissues swell, and drugs are prescribed to suppress the cascade. This framework has produced effective therapies, yet it leaves several fundamental questions unresolved: why does inflammation become chronic in some individuals but not others? Why do conditions as seemingly distinct as rheumatoid arthritis, inflammatory bowel disease, metabolic syndrome, depression, and neurodegeneration so often cluster within the same patient?

In parallel, over the past 20 years, a different understanding has taken shape, one that reframes inflammation not as a standalone immune malfunction but as a regulatory problem. Landmark work by Kevin J. Tracey and colleagues demonstrated that inflammatory activity is under direct neural control. A seminal 2000 study also showed that electrical stimulation of the vagus nerve rapidly suppressed systemic tumor necrosis factor (TNF) release in the presence of endotoxins in the bloodstream. This study established the existence of a hardwired neural circuit (the inflammatory reflex) that can restrain immune activity in real time.

What initially appeared as a novel experimental finding has since evolved into a broader neuro-immune framework. Subsequent studies have extended this model beyond acute endotoxin exposure, demonstrating that vagus-mediated signaling can modify inflammatory tone across chronic disease states, aging, and metabolic dysfunction. More recent work has mapped specific brainstem nuclei and vagal pathways that mediate sensing of peripheral immune signals and coordinate rapid anti-inflammatory responses.

Neuro-immune paradigm shift

Within the traditional immunology framework, the immune system was viewed as largely autonomous, with the brain responding only secondarily through sickness behavior or endocrine stress pathways. Tracey’s work overturned this view by revealing a bidirectional neuro-immune dialogue. Immune cells signal the brain through direct neural signals carried by vagal afferent nerves. In response, the brain deploys rapid and targeted efferent signals that suppress inflammatory output at its source.

Crucially, the inflammatory reflex operates on the scale of seconds. Unlike hormonal responses, which unfold over minutes to hours, vagal efferent signaling can inhibit TNF, IL-1β, and IL-6 almost immediately. This speed and specificity laid the groundwork for the emerging field of bioelectronic medicine, which seeks to modulate disease by targeting neural circuits rather than indiscriminately blocking molecular pathways.

Failure of this reflex is increasingly implicated in inflammaging: the age-related accumulation of unresolved inflammation that accelerates cardiovascular disease, neurodegeneration, sarcopenia, and frailty. Vagus nerve stimulation (VNS) emerges from this model not as a workaround but as a logical strategy: rather than blocking inflammatory molecules after they are released, VNS aims to re-engage the neural circuits that usually keep immune responses proportional, time-limited, and self-resolving.

The inflammatory reflex as a control system

The inflammatory reflex functions as a closed-loop control system, analogous to other physiological regulatory circuits such as baroreflex control of blood pressure or glucose regulation. Like these systems, it consists of three essential components: signal detection, central integration, and effector response.

Peripheral immune activation generates cytokines and inflammatory mediators that are detected not only by immune receptors but also by sensory pathways of the vagus nerve. Afferent vagal fibers relay this information to brainstem nuclei, where immune signals are integrated with physiological context, including metabolic state, circadian cues, and psychological stress.

When inflammatory activity exceeds an appropriate threshold, efferent vagal output is engaged. Through downstream signaling pathways, including cholinergic modulation of macrophage activity, pro-inflammatory cytokine production is rapidly restrained. This inhibitory feedback limits the magnitude and duration of immune activation, allowing inflammation to resolve once the initiating threat has passed.

Chronic inflammation emerges when this regulatory loop is impaired. Reduced vagal tone blunts inhibitory signaling, lowering the threshold for immune activation and delaying termination of the inflammatory response. The result is not excessive immune reactivity per se, but loss of effective restraint; a failure of resolution rather than an overreaction.

Chronic disease, as a failed neural regulation

Reduced vagal tone is a consistent feature of a broad spectrum of chronic diseases, including rheumatoid arthritis, inflammatory bowel disease, metabolic syndrome, atherosclerosis, depression, and neurodegenerative disorders. Although these conditions differ clinically, they share a common biological signature: persistent low-grade inflammation coupled with impaired resolution.

The inflammatory reflex offers a unifying framework. Rather than viewing each disorder as an independent pathology driven by disease-specific triggers, they can be understood as manifestations of shared failure of neural regulation. When vagal inhibitory control is compromised, immune responses become exaggerated, prolonged, and self-perpetuating, driving tissue damage, metabolic dysfunction, and neuroimmune sensitization.

From this perspective, chronic inflammatory diseases are less a problem of immune excess and more a problem of regulatory failure. The nervous system, via the vagus nerve, emerges as a central coordinator of immune homeostasis, the decline of which with stress and aging may be a key driver of modern chronic disease. It also helps explain why chronic diseases often cluster within individuals and why interventions that improve overall physiological resilience, such as physical activity, sleep optimization, stress reduction, and metabolic health, exert broad anti-inflammatory effects across multiple organ systems.

The inflammatory reflex is an immunity regulator

Experimental and clinical evidence consistently support the inflammatory reflex as the core regulator of immune activity. In animal models, vagus nerve stimulation suppresses the release of inflammatory cytokines in diverse conditions, including sepsis, arthritis, colitis, and post-operative inflammation. These effects are rapid and reproducible, supporting the conclusion that they reflect a defined neural circuit.

Human data are closely aligned with these findings. Higher vagal tone, most commonly assessed by high-frequency heart rate variability (HRV), is inversely associated with circulating inflammatory markers, including IL-6, TNF-α, and C-reactive protein.

Individuals with higher HRV demonstrate a lower baseline inflammatory burden, faster resolution following immune challenge, and greater physiological adaptability to stress. Conversely, reduced vagal tone predicts increased inflammatory activity and poorer outcomes in multiple disease states.

Clinical trials have translated these observations into therapeutic concepts. In patients with rheumatoid arthritis, implanted vagus nerve stimulators reduce disease activity scores and cytokine production in those resistant to conventional therapy.

Similar benefits have been observed in patients with Crohn’s disease, with improvements in inflammatory markers and clinical symptoms. Importantly, these interventions were well tolerated, with minimal side effects and no evidence of global immunosuppression.

This is where vagus nerve stimulation differs fundamentally from pharmacologic anti-inflammatory approaches, and most drugs act by blocking specific cytokines or by suppressing immune cell activity more broadly. VNS, by contrast, modulates an upstream control system. It does not target a single molecule, but an entire regulatory circuit. This allows inflammation to be dynamically tuned rather than shut down indiscriminately, thereby reducing the risk of infection or immune rebound.

Taken together, these findings suggest that vagal tone functions not only as a biomarker but also as a systems-level regulator of the inflammatory set-point. The inflammatory reflex integrates immune activity with the metabolic state, circadian rhythms, psychological stress, and cardiorespiratory fitness.

Factors such as chronic stress, sleep disruption, sedentary behavior, insulin resistance, and aging converge on a shared pathway: suppression of vagal signaling and loss of inhibitory immune control.

What exactly is the vagus nerve?

Also called ‘cranial nerve X’, the vagus nerve derives its name from the Latin word vagus, which means ‘wandering,’ an apt description of its extensive anatomical reach. Originating in the brainstem, it descends through the neck and thorax to innervate the heart, lungs, liver, pancreas, and gastrointestinal tract, making it the body’s primary parasympathetic nerve.

Functionally, it is predominantly sensory, and 80-90% of its fibers carry information from peripheral organs back to the brain. These sensory signals are transmitted to the brainstem and then distributed to autonomic and higher regulatory centers involved in physiological and emotional control. The remaining 10-20% of fibers carry outgoing parasympathetic signals that coordinate heart rate, gastrointestinal function, and immune regulation.

The vagus nerve is composed of multiple fiber types. Unmyelinated C-fibers are exceptionally responsive to inflammatory signals, while myelinated A- and B-fibers support faster reflexes, such as cardiovascular control. This mixed architecture enables the vagus nerve to function, sampling internal conditions and adjusting physiological responses in real time.

How vagal nerve stimulation works

Vagus nerve stimulation does not add a foreign signal to the body. It amplifies and restores an existing signal. By increasing vagal efferent output, stimulation strengthens the timing and intensity of the brain’s inhibitory messages to immune cells, particularly innate immune cells such as macrophages. Functionally, this means inflammatory responses are shortened rather than suppressed.

Cytokine release is reduced when it becomes excessive, whereas antimicrobial functions, such as pathogen clearance, remain intact. Instead of forcing the immune system into silence, stimulation helps re-establish its ability to escalate when needed, and stand down when the threat has passed.

Vagus nerve and communication

Around 90% of vagal fibers innervate the gut. The gastrointestinal tract is the body’s largest immune interface, containing the majority of immune cells and the densest microbial ecosystem. Unsurprisingly, it is also a significant source of inflammatory signals that communicate with the brain via the vagus nerve.

Vagal sensory neurons do not directly ‘touch’ what is inside the gut. Instead, it relies on messenger cells within the intestinal lining to inform it what is occurring. Specialized gut cells called enteroendocrine cells (EECs) act like biological sensors and translators. They can detect nutrients and chemical by-products made by gut microbes, even though microbes themselves never contact nerve endings.

When certain gut bacteria break down the amino acid tryptophan, they produce compounds that trigger Trpa1 receptors on these EECs. This activation causes cells to release serotonin (5-HT) rapidly. Serotonin then stimulates nearby enteric motor neurons and transmits signals via the vagus nerve to the brain. In this way, the gut microbiome can rapidly communicate with the brain indirectly via EECs.

Stress, permeability, and inflammatory looping

The vagus nerve continuously monitors gastrointestinal activity. When the gut barrier weakens or the microbiome becomes imbalanced, immune cells release inflammatory signals, and microbial by-products leak through the intestinal lining. These signals are picked up by the vagus nerve and relayed to the brain. Under normal conditions, the brain responds by sending calming signals back down the vagus nerve.

These signals instruct immune cells, particularly macrophages, to suppress inflammation and initiate repair. This is how the body prevents a short-term immune response from becoming chronic.

Chronic stress disrupts this balance. Stress hormones increase gut permeability and enhance immune reactivity as more microbial products enter the tissue and inflammation rises, thereby further stimulating the stress response. Over time, this creates a self-reinforcing cycle: stress weakens the gut, the gut fuels inflammation, and inflammation keeps the nervous system in a state of high alert.

Macrophages can either promote inflammation or help resolve it. Signals from the vagus nerve act like switch, nudging these cells away from attack mode and toward healing. When vagal tone is low, as is common in chronic stress, metabolic dysfunction, and inflammatory disease, that switch doesn’t flip effectively. Inflammation stays ‘on’ longer than it should.

This calming signal does not shut down the immune system. It selectively reduces excessive inflammatory signaling while preserving the body’s ability to fight infection. In other words, it restores control versus suppression. When this neural braking system fails, inflammation does not fully resolve. What starts as a transient gastrointestinal disturbance can gradually escalate into widespread, low-grade inflammation throughout the body.

This helps explain why chronic inflammatory conditions often show up alongside gut symptoms, stress sensitivity, fatigue, and autonomic imbalance; not as separate issues, but as part of the same broken feedback loop.

The vagus nerve as a volume dial

VNS can be delivered invasively via implanted devices or noninvasively via transcutaneous approaches, but all methods share the same goal: restoring effective neural braking of inflammation.

What makes this gut-brain-immune system especially powerful is its precision. Most anti-inflammatory drugs work like a blanket. They can quiet inflammation, but they do so by broadly suppressing the immune system, which can leave the body more vulnerable to infection. The vagus nerve works differently. It acts more like a volume dial than an off switch.

When inflammation begins to spiral under chronic stress, gut permeability, or dysbiosis, the vagus nerve selectively targets harmful immune signals. It turns down excessive cytokine release without shutting down the immune system’s core defenses. Macrophages can still do their job, continuing to recognize, engulf, and clear bacteria and damaged cells.

An overly active immune system rarely causes chronic disease. It is caused by one that stays activated for too long. The vagus nerve helps restore the response to balance once the threat has passed, preventing inflammation from progressing to ongoing tissue damage.

When this neural ‘brake’ is working well, the body can mount a strong defense and then stand down efficiently. When vagal tone is low, inflammation loses its stop signal. The immune response lingers, spills beyond the gut, and contributes to fatigue, pain, metabolic dysfunction, and mood changes.

Together, this reframes inflammation as something to regulate. The goal is to restore the body’s ability to respond, resolve, and recover.

In conclusion

Chronic inflammation is rarely the result of an immune system that is too strong. More often, it reflects an immune response that has lost its ability to stand down. The evidence reviewed here supports a shift away from viewing inflammation solely as a biochemical cascade to be suppressed and toward understanding it as a regulated physiological process that depends on intact neural control.

The inflammatory reflex provides a coherent framework for this shift. Situating immune activity within a closed-loop neuroimmune control system helps explain why chronic inflammatory diseases cluster, why psychological stress and metabolic dysfunction so reliably worsen the inflammatory burden, and why resolution often fails despite aggressive molecular blockade. In this context, reduced vagal tone is not merely a correlate of disease severity but a plausible upstream driver of impaired inflammatory restraint.

This reframing has important clinical implications. If chronic inflammation reflects a failure of neural regulation rather than immune excess, then strategies that restore inhibitory control become central rather than adjunctive. Interventions that improve vagal tone, whether through physiological conditioning, behavioral inputs, or direct immunomodulation, are not alternative approaches to managing inflammation. They target the regulatory architecture that governs immune proportionality and resolution.

Understanding inflammation through this regulatory lens does not diminish the value of pharmacological therapies. Instead, it clarifies their limitations. Blocking cytokines after release may reduce symptoms, but it does not restore the system that determines when immune responses begin, how intensely they proceed, or when they end. Restoring that system requires engaging the neural circuits that evolved to coordinate immune activity with the broader physiological state.

From framework to intervention

Join us for Part II, where we will focus on VNS as a direct clinical application of this regulatory model. Building on the physiology outlined here, it examines how targeted neuromodulation can re-engage the inflammatory reflex, restore inhibitory control, and reduce inflammatory burden without global immunosuppression.

We will examine the current clinical evidence for VNS across inflammatory and immune-mediated conditions, compare invasive and non-invasive approaches, and examine how neuromodulation fits within a broader strategy that includes lifestyle interventions known to influence vagal tone. Together, these approaches point toward a more precise and physiologically aligned way of managing chronic inflammation; one that prioritizes regulation, resolution, and resilience over suppression alone.

If you’re living with one or more lifestyle-related chronic conditions and are ready to move beyond symptom management, I offer personalized consultations focused on physiology, labs, and upstream drivers of disease. Book a discovery appointment to explore your symptoms, review relevant biomarkers, and develop a targeted, evidence-informed plan. Start your health journey with me.

References

Ahmed, U., Chang, Y. C., Zafeiropoulos, S., Nassrallah, Z., Miller, L., & Zanos, S. (2022). Strategies for precision vagus neuromodulation. Bioelectronic Medicine, 8(1), Article 9. https://doi.org/10.1186/s42234-022-00091-1

Badran, B. W., & Austelle, C. W. (2022). The future is noninvasive: A brief review of the evolution and clinical utility of vagus nerve stimulation. Focus, 20(1), 3–7. https://doi.org/10.1176/appi.focus.20210023

Báez-Pagán, C. A., Delgado-Vélez, M., & Lasalde-Dominicci, J. A. (2015). Activation of the macrophage α7 nicotinic acetylcholine receptor and control of inflammation. Journal of Neuroimmune Pharmacology, 10(3), 468–476. https://doi.org/10.1007/s11481-015-9601-5

Bellocchi, C., Carandina, A., Montinaro, B., Targetti, E., Furlan, L., Rodrigues, G. D., Tobaldini, E., & Montano, N. (2022). The interplay between autonomic nervous system and inflammation across systemic autoimmune diseases. International Journal of Molecular Sciences, 23(5), Article 2449. https://doi.org/10.3390/ijms23052449

Bonaz, B., Sinniger, V., Hoffmann, D., Clarencon, D., Mathieu, N., Dantzer, C., & Pellissier, S. (2016). Chronic vagus nerve stimulation in Crohn’s disease: A 6-month follow-up pilot study. Neurogastroenterology & Motility, 28(6), 948–953. https://doi.org/10.1111/nmo.12792

Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000). Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 405(6785), 458–462. https://doi.org/10.1038/35013070

Caravaca, A. S., Gallina, A. L., Tarnawski, L., Shavva, V. S., Colas, R. A., Dalli, J., Malin, S. G., Hult, H., Arnardottir, H., & Olofsson, P. S. (2022). Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the α7nAChR subunit. Proceedings of the National Academy of Sciences, 119(22), Article e2023285119. https://doi.org/10.1073/pnas.2023285119

Cooper, T. M., McKinley, P. S., Seeman, T. E., Choo, T. H., Lee, S., & Sloan, R. P. (2015). Heart rate variability predicts levels of inflammatory markers: Evidence for the vagal anti-inflammatory pathway. Brain, Behavior, and Immunity, 49, 94–100. https://doi.org/10.1016/j.bbi.2014.12.017

D’Haens, G., Eberhardson, M., Cabrijan, Z., Danese, S., van den Berg, R., Löwenberg, M., Fiorino, G., Schuurman, P. R., Lind, G., Almqvist, P., Olofsson, P. S., Tracey, K. J., Hanauer, S. B., Zitnik, R., Chernoff, D., & Levine, Y. A. (2023). Neuroimmune modulation through vagus nerve stimulation reduces inflammatory activity in Crohn’s disease patients: A prospective open-label study. Journal of Crohn’s and Colitis, 17(12), 1897–1909. https://doi.org/10.1093/ecco-jcc/jjad151

Falvey, A. (2022). Vagus nerve stimulation and inflammation: Expanding the scope beyond cytokines. Bioelectronic Medicine, 8(1), Article 19. https://doi.org/10.1186/s42234-022-00100-3

Falvey, A., Metz, C. N., Tracey, K. J., & Pavlov, V. A. (2022). Peripheral nerve stimulation and immunity: The expanding opportunities for providing mechanistic insight and therapeutic intervention. International Immunology, 34(2), 107–118. https://doi.org/10.1093/intimm/dxab068

Huston, J. M., & Tracey, K. J. (2011). The pulse of inflammation: Heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. Journal of Internal Medicine, 269(1), 45–53. https://doi.org/10.1111/j.1365-2796.2010.02321.x

Kelly, M. J., Breathnach, C., Tracey, K. J., & Donnelly, S. C. (2022). Manipulation of the inflammatory reflex as a therapeutic strategy. Cell Reports Medicine, 3(7), Article 100696. https://doi.org/10.1016/j.xcrm.2022.100696

Koopman, F. A., Chavan, S. S., Miljko, S., Grazio, S., Sokolovic, S., Schuurman, P. R., Mehta, A. D., Levine, Y. A., Faltys, M., Zitnik, R., Tracey, K. J., & Tak, P. P. (2016). Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proceedings of the National Academy of Sciences, 113(29), 8284–8289. https://doi.org/10.1073/pnas.1605635113

Ma, L., Wang, H.-B., & Hashimoto, K. (2025). The vagus nerve: An old but new player in brain–body communication. Brain, Behavior, and Immunity, 124, 111–114. https://doi.org/10.1016/j.bbi.2024.11.023

Mills, C. D. (2015). Anatomy of a discovery: M1 and M2 macrophages. Frontiers in Immunology, 6, Article 212. https://doi.org/10.3389/fimmu.2015.00212

Pavlov, V. A., & Tracey, K. J. (2012). The vagus nerve and the inflammatory reflex—linking immunity and metabolism. Nature Reviews Endocrinology, 8(12), 743–754. https://doi.org/10.1038/nrendo.2012.189

Pavlov, V. A., & Tracey, K. J. (2022). Bioelectronic medicine: Preclinical insights and clinical advances. Neuron, 110(21), 3627–3644. https://doi.org/10.1016/j.neuron.2022.09.003

Sohn, R., & Jenei-Lanzl, Z. (2023). Role of the sympathetic nervous system in mild chronic inflammatory diseases: Focus on osteoarthritis. Neuroimmunomodulation, 30(1), 143–166. https://doi.org/10.1159/000531798

Tracey, K. J. (2002). The inflammatory reflex. Nature, 420(6917), 853–859. https://doi.org/10.1038/nature01321

Tracey, K. J. (2007). Physiology and immunology of the cholinergic antiinflammatory pathway. Journal of Clinical Investigation, 117(2), 289–296. https://doi.org/10.1172/JCI30555

Veldman, F., Hawinkels, K., & Keszthelyi, D. (2025). Efficacy of vagus nerve stimulation in gastrointestinal disorders: A systematic review. Gastroenterology Report, 13, Article goaf009. https://doi.org/10.1093/gastro/goaf009

Ye, L., Bae, M., Cassilly, C. D., Jabba, S. V., Thorpe, D. W., Martin, A. M., Lu, H. Y., Wang, J., Thompson, J. D., Lickwar, C. R., Poss, K. D., Keating, D. J., Jordt, S. E., Clardy, J., Liddle, R. A., & Rawls, J. F. (2021). Enteroendocrine cells sense bacterial tryptophan catabolites to activate enteric and vagal neuronal pathways. Cell Host & Microbe, 29(2), 179–196. https://doi.org/10.1016/j.chom.2020.11.011